Literature DB >> 27186414

IL-17 induces EMT via Stat3 in lung adenocarcinoma.

Qi Huang1, Jieli Han1, Jinshuo Fan1, Limin Duan1, Mengfei Guo1, Zhilei Lv1, Guorong Hu1, Lian Chen1, Feng Wu1, Xiaonan Tao1, Juanjuan Xu1, Yang Jin1.   

Abstract

Epithelial-mesenchymal transition (EMT) plays a vital role in lung inflammatory diseases, including lung cancer. However, the role and mechanism of action of the proinflammatory cytokine IL-17 in EMT in lung adenocarcinoma remain unresolved. In our study, we discovered that the expression of N-cadherin, Vimentin, Snail1, Snail2, and Twist1 was positively correlated with IL-17 expression, while E-cadherin expression was negatively correlated with IL-17 expression in human lung adenocarcinoma tissues. Moreover, we confirmed that IL-17 promoted EMT in A549 and Lewis lung carcinoma (LLC) cells in vitro by upregulating N-cadherin, Vimentin, Snail1, Snail2, and Twist1 expression and downregulating E-cadherin expression. Stat3 was activated in IL-17-treated A549 and LLC cells, and Stat3 inhibition or siRNA knockdown notably reduced IL-17-induced EMT in A549 and LLC cells. Thus, IL-17 promotes EMT in lung adenocarcinoma via Stat3 signaling; these observations suggest that targeting IL-17 and EMT are potential novel therapeutic strategies for lung cancer.

Entities:  

Keywords:  IL-17; Snail1; Snail2; Stat3; Twist1; lung adenocarcinoma

Year:  2016        PMID: 27186414      PMCID: PMC4859671     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  39 in total

Review 1.  The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.

Authors:  Steven L Wood; Maria Pernemalm; Philip A Crosbie; Anthony D Whetton
Journal:  Cancer Treat Rev       Date:  2013-10-15       Impact factor: 12.111

2.  Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-κB/ZEB1 signal pathway.

Authors:  Kuo Gu; Ming-Ming Li; Jing Shen; Fang Liu; Jing-Yan Cao; Shi Jin; Yan Yu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 3.  The emerging role of T cell cytokines in non-small cell lung cancer.

Authors:  Markus F Neurath; Susetta Finotto
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-28       Impact factor: 7.638

Review 4.  The EMT regulator slug and lung carcinogenesis.

Authors:  Jin-Yuan Shih; Pan-Chyr Yang
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

5.  Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.

Authors:  Xi Chen; Qichao Xie; Xiaoming Cheng; Xinwei Diao; Yue Cheng; Jiankun Liu; Wei Xie; Zhengtang Chen; Bo Zhu
Journal:  Cancer Sci       Date:  2010-09-01       Impact factor: 6.716

6.  IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β1 to induce bronchial epithelial-mesenchymal transition (EMT).

Authors:  Xiaoying Ji; Jinxiu Li; Li Xu; Wenjing Wang; Ming Luo; Shuangling Luo; Libing Ma; Keng Li; Subo Gong; Long He; Zhijun Zhang; Ping Yang; Zhiguang Zhou; Xudong Xiang; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

7.  Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.

Authors:  Lei Zhang; Li Tao; Tianlu Shi; Feng Zhang; Xiaobo Sheng; Yuzhu Cao; Shizhong Zheng; Aiyun Wang; Wenhui Qian; Ling Jiang; Yin Lu
Journal:  IUBMB Life       Date:  2015-10-10       Impact factor: 3.885

Review 8.  Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.

Authors:  Mousumi Tania; Md Asaduzzaman Khan; Junjiang Fu
Journal:  Tumour Biol       Date:  2014-06-02

9.  IL-17 promoted metastasis of non-small-cell lung cancer cells.

Authors:  Qinchuan Li; Yang Han; Guangru Fei; Zhongliang Guo; Tao Ren; Zhongmin Liu
Journal:  Immunol Lett       Date:  2012-10-23       Impact factor: 3.685

10.  Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal.

Authors:  Li Li; Rui Han; Hualiang Xiao; Caiyu Lin; Yubo Wang; Hao Liu; Kunlin Li; Hengyi Chen; Fenfen Sun; Zhenzhou Yang; Jianxin Jiang; Yong He
Journal:  Clin Cancer Res       Date:  2014-03-18       Impact factor: 12.531

View more
  18 in total

1.  TRPC1 intensifies house dust mite-induced airway remodeling by facilitating epithelial-to-mesenchymal transition and STAT3/NF-κB signaling.

Authors:  Qinqin Pu; Yuanyu Zhao; Yuyang Sun; Ting Huang; Ping Lin; Chuanmin Zhou; Shugang Qin; Brij B Singh; Min Wu
Journal:  FASEB J       Date:  2018-08-01       Impact factor: 5.191

2.  Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma.

Authors:  Jon M Evasovic; Cherie A Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-27       Impact factor: 5.464

3.  Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model.

Authors:  Qiuyang Zhang; Sen Liu; Dongxia Ge; David M Cunningham; Feng Huang; Lin Ma; Thomas P Burris; Zongbing You
Journal:  Prostate       Date:  2017-02-27       Impact factor: 4.104

4.  Role of IL-17A in murine models of COPD airway disease.

Authors:  Haruhiko Yanagisawa; Mitsuo Hashimoto; Shunsuke Minagawa; Naoki Takasaka; Royce Ma; Catherine Moermans; Saburo Ito; Jun Araya; Alison Budelsky; Amanda Goodsell; Jody L Baron; Stephen L Nishimura
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-12-02       Impact factor: 5.464

5.  An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines.

Authors:  Pedro O Flores-Villanueva; Malathesha Ganachari; Heinner Guio; Jaime A Mejia; Julio Granados
Journal:  J Immunol       Date:  2018-03-19       Impact factor: 5.422

6.  Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway.

Authors:  Xinxin Yu; Yan Zheng; Xuchao Zhu; Xiaomei Gao; Chaoqun Wang; Yuanyuan Sheng; Wei Cheng; Lunxiu Qin; Ning Ren; Huliang Jia; Qiongzhu Dong
Journal:  Oncol Lett       Date:  2018-08-08       Impact factor: 2.967

7.  Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.

Authors:  Claire L Meaney; Adriana Zingone; Derek Brown; Yunkai Yu; Liang Cao; Bríd M Ryan
Journal:  Oncotarget       Date:  2017-06-20

8.  Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation.

Authors:  Ting Wang; Yuan Liu; Jing-Feng Zou; Zhen-Shun Cheng
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

9.  Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets.

Authors:  Eumorphia G Konstantakou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Zoi I Litou; Ourania A Konstandi; Aikaterini F Giannopoulou; Ema Anastasiadou; Gerassimos E Voutsinas; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

10.  Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.

Authors:  Spiros A Vlahopoulos
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.